Wound Management Devices Market by Product (Therapy Devices, Wound closure Devices, and Others), Application (Burns, Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds, and Others), and End User (Hospitals, Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 20192026
- Published Date: 2020-11-18
- Report ID: 18174
- Pages: 240
-
Format:
The global wound management devices market was valued at $13,396.8 million in 2018 and is projected to reach $18,818.4 million by 2026, registering a CAGR of 4.3% from 2019 to 2026. Wounds are one of the most common afflictions that affect billions of people worldwide. Wounds can be classified into acute and chronic based on the severity. Acute wounds are often recovered by natural healing process whereas chronic wounds are hard-to-heal due to complications from cardiovascular diseases (CVD), obesity, diabetes, and other lifestyle diseases. Thus, addressing these wounds require efficient and cost-effective wound management devices and practices, thereby, increasing the need for better wound healing products.
As per data published by the U.S. National Institute of Health, in 2017, wounds or chronic wounds affect approximately 6.5 million of the U.S. population and the number is likely to increase in the coming years. In addition, major pharmaceutical companies are introducing advanced wound care management devices for faster recovery of patients from acute and chronic wounds. For instance, in 2017, Smith & Nephew launched a handheld imaging device MolecuLight i:X in Europe that is specifically used in measuring wound surface area and detect harmful bacteria within it.
Factors such as increasing geriatric population across the globe, need for fast acting wound closure devices for prevention of blood loss during surgeries, and rise in number of people suffering from chronic wounds and ulcers due to various diseases such as diabetes and CVDs primarily drives the market growth. In addition, technological advancements in wound healing procedures adopted by hospitals and clinics are further expected to boost the market growth. However, higher cost of treatments involved in wound management techniques is anticipated to restrain the market globally. Moreover, lack of proper reimbursement policies in developing countries also hamper the growth of the wound management devices market. However, introduction of novel therapies for wound healing and growing number of therapy approvals such as negative pressure wound therapies and extracorporeal shock wave therapies, create newer opportunities for the growth of the market.
The wound management devices market is segmented on the basis of product, application, end user and region. Based on the product, the market is classified into therapy devices, wound closure devices and others. Based on the application, the wound management devices market is divided into burns, diabetic foot ulcers, pressure ulcers, surgical wounds and others. Based on end user, the market is segmented into hospitals, clinics, home care settings and others. Region wise, the market is further analysed across North America, Europe, Asia-Pacific and LAMEA.
Prominent players in the market have adopted various strategies such as developing advanced wound care therapies and product launch for maintaining their share in the wound management devices market thereby addressing the evolving healthcare needs among patients and healthcare providers. Some of the key players of the market include Baxter International Inc., Coloplast A/S, ConvaTec Inc., Derma Sciences Inc., Hollister Inc., Johnson & Johnson, 3M Company, Medtronic Plc., Mlnlycke Health Care, and Smith & Nephew.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
Therapy Devices
Wound closure Devices
Others
By Application
Burns
Diabetic Foot Ulcers
Pressure ulcers
Surgical wounds
Others
By End User
Hospitals
Clinics
Others
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o Spain
o Italy
o UK
o Rest of Europe
Asia-Pacific
o Japan
o India
o China
o Australia
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Baxter International Inc.
Coloplast A/S
ConvaTec Inc.
Derma Sciences Inc.
Hollister Inc.
Johnson & Johnson
3M Company
Medtronic Plc.
Mlnlycke Health Care
Smith & Nephew
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Patent Analysis
3.3.1.By Region
3.3.2.By Applicant
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Rising geriatric population
3.4.1.2.Increase in diabetic population
3.4.1.3.Growing number of surgeries
3.4.2.Restraints
3.4.2.1.Higher costs of wound care and management
3.4.2.2.Reluctance in adoption of wound management therapies
3.4.3.Opportunities
3.4.3.1.Preference of advanced wound care devices
CHAPTER 4:WOUND MANAGEMENT DEVICES MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Therapy Devices
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Wound Closure Devices
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Other Devices
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:WOUND MANAGEMENT DEVICES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Burns
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Diabetic Foot Ulcers
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Pressure ulcers
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Surgical wounds
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Others
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
CHAPTER 6:WOUND MANAGEMENT DEVICES MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Clinics
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Others
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:GLOBAL WOUND MANAGEMENT DEVICES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by product
7.2.3.Market size and forecast, by application
7.2.4.Market size and forecast, by end user
7.2.5.Market size and forecast, by country
7.2.5.1.U.S. market size and forecast, by product
7.2.5.2.U.S. market size and forecast, by application
7.2.5.3.U.S. market size and forecast, by end user
7.2.5.4.Canada market size and forecast, by product
7.2.5.5.Canada market size and forecast, by application
7.2.5.6.Canada market size and forecast, by end user
7.2.5.7.Mexico market size and forecast, by product
7.2.5.8.Mexico market size and forecast, by application
7.2.5.9.Mexico market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Market size and forecast, by product
7.3.3.Market size and forecast, by application
7.3.4.Market size and forecast, by end user
7.3.5.Market size and forecast, by country
7.3.5.1.Germany market size and forecast, by product
7.3.5.2.Germany market size and forecast, by application
7.3.5.3.Germany market size and forecast, by end user
7.3.5.4.France market size and forecast, by product
7.3.5.5.France market size and forecast, by application
7.3.5.6.France market size and forecast, by end user
7.3.5.7.UK market size and forecast, by product
7.3.5.8.UK market size and forecast, by application
7.3.5.9.UK market size and forecast, by end user
7.3.5.10.Italy market size and forecast, by product
7.3.5.11.Italy market size and forecast, by application
7.3.5.12.Italy market size and forecast, by end user
7.3.5.13.Spain market size and forecast, by product
7.3.5.14.Spain market size and forecast, by application
7.3.5.15.Spain market size and forecast, by end user
7.3.5.16.Rest of Europe market size and forecast, by product
7.3.5.17.Rest of Europe market size and forecast, by application
7.3.5.18.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by product
7.4.3.Market size and forecast, by application
7.4.4.Market size and forecast, by end user
7.4.5.Market size and forecast, by country
7.4.5.1.Japan market size and forecast, by product
7.4.5.2.Japan market size and forecast, by application
7.4.5.3.Japan market size and forecast, by end user
7.4.5.4.China market size and forecast, by product
7.4.5.5.China market size and forecast, by application
7.4.5.6.China market size and forecast, by end user
7.4.5.7.India market size and forecast, by product
7.4.5.8.India market size and forecast, by application
7.4.5.9.India market size and forecast, by end user
7.4.5.10.Australia market size and forecast, by product
7.4.5.11.Australia market size and forecast, by application
7.4.5.12.Australia market size and forecast, by end user
7.4.5.13.South Korea market size and forecast, by product
7.4.5.14.South Korea market size and forecast, by application
7.4.5.15.South Korea market size and forecast, by end user
7.4.5.16.Rest of Asia-Pacific market size and forecast, by product
7.4.5.17.Rest of Asia-Pacific market size and forecast, by application
7.4.5.18.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.Market size and forecast, by product
7.5.3.Market size and forecast, by application
7.5.4.Market size and forecast, by end user
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil market size and forecast, by product
7.5.5.2.Brazil market size and forecast, by application
7.5.5.3.Brazil market size and forecast, by end user
7.5.5.4.Saudi market size and forecast, by product
7.5.5.5.Saudi market size and forecast, by application
7.5.5.6.Saudi market size and forecast, by end user
7.5.5.7.South Africa market size and forecast, by product
7.5.5.8.South Africa market size and forecast, by application
7.5.5.9.South Africa market size and forecast, by end user
7.5.5.10.Rest of LAMEA market size and forecast, by product
7.5.5.11.Rest of LAMEA market size and forecast, by application
7.5.5.12.Rest of LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.BAXTER INTERNATIONAL INC.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.Coloplast A/S
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.ConvaTec Inc.
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.DERMA SCIENCES INC.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.Hollister Inc.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.6.Johnson & Johnson
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.1.Key strategic moves and developments
8.7.3M Company
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.Medtronic Plc.
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.9.Mlnlycke Health Care
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.Smith & Nephew
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
